https://orcid.org/0000-0002-7496-8167
References
- Molinaro A, Wahlstrom A, Marschall HU. Role of bile acids in metabolic control. Trends Endocrinol Metab. 2018;29(1):31–41.
- Schaap FG, Trauner M, Jansen PL. Bile acid receptors as targets for drug development. Nat Rev Gastroenterol Hepatol. 2014;11(1):55–67.
- Li-Hawkins J, Gafvels M, Olin M, et al. Cholic acid mediates negative feedback regulation of bile acid synthesis in mice. J Clin Invest. 2002;110(8):1191–1200.
- Kaur A, Patankar JV, de Haan W, et al. Loss of Cyp8b1 improves glucose homeostasis by increasing GLP-1. Diabetes. 2015;64(4):1168–1179.
- Rudling M. Understanding mouse bile acid formation: is it time to unwind why mice and rats make unique bile acids? J Lipid Res. 2016;57(12):20978.
- Bonde Y, Eggertsen G, Rudling M. Mice abundant in muricholic bile acids show resistance to dietary induced steatosis, weight gain, and to impaired glucose metabolism. PLoS One. 2016;11(1):e0147772.
- Bertaggia E, Jensen KK, Castro-Perez J, et al. Cyp8b1 ablation prevents Western diet-induced weight gain and hepatic steatosis because of impaired fat absorption. Am J Physiol Endocrinol Metab. 2017;313(2):E121–E33.
- Brommage R. Validation and calibration of DEXA body composition in mice. Am J Physiol Endocrinol Metab. 2003;285(3):E454–9.
- Ahren B, Simonsson E, Scheurink AJ, et al. Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice. Metabolism. 1997;46(1):97–106.
- Clark AM, Sousa KM, Jennings C, et al. Continuous flow enzyme assay on a microfluidic chip for monitoring glycerol secretion from cultured adipocytes. Anal Chem. 2009;81(6):2350–2356.
- Moody AJ, Stan MA, Stan M, et al. A simple free fat cell bioassay for insulin. Horm Metab Res. 1974;6(1):12–16.
- Zhao LJ, Zhang SF. Activation of TGR5 promotes mitochondrial biogenesis in human aortic endothelial cells. Biochem Biophys Res Commun. 2018;500(4):952–957.
- Watanabe M, Houten SM, Mataki C, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006;439(7075):484–489.
- Watanabe M, Horai Y, Houten SM, et al. Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure. J Biol Chem. 2011;286(30):26913–26920.
- Broeders EP, Nascimento EB, Havekes B, et al. The Bile Acid Chenodeoxycholic Acid Increases Human Brown Adipose Tissue Activity. Cell Metab. 2015;22(3):418–426.
- Prawitt J, Caron S, Staels B. Bile acid metabolism and the pathogenesis of type 2 diabetes. Curr Diab Rep. 2011;11(3):160–166.
- Hu X, Bonde Y, Eggertsen G, et al. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism. J Intern Med. 2014;275(1):27–38.
- Zhou H, Zhou S, Gao J, et al. Upregulation of bile acid receptor TGR5 and nNOS in gastric myenteric plexus is responsible for delayed gastric emptying after chronic high-fat feeding in rats. Am J Physiol Gastrointest Liver Physiol. 2015;308(10):G863–73.
- Nauck MA, Meier JJ. Incretin hormones: their role in health and disease. Diabetes Obes Metab. 2018;20(Suppl 1):5–21.
- Sigurdsson V, Takei H, Soboleva S, et al. Bile acids protect expanding hematopoietic stem cells from unfolded protein stress in fetal liver. Cell Stem Cell. 2016;18(4):522–532.